Pelvic Pain Support Group
Thursday, April 1st, 2010Marina Ruzimovsky led a superb Pelvic Pain Support Group on February 28th.
Topics discussed included…
*The male chronic prostatitis/chronic patient: current management strategies
*New concepts of patient evaluation: Examination of the multiple facets of patient presentation (co-morbid conditions) rather than just the bladder or prostate.
*Novel and evolving approaches to the treatment of pelvic pain
The role of…
Cannabanoids
Liposomes
Nerve Growth Factor Immunoglobulin (Tanezumab)
Physical Therapy
Posterior tibial nerve stimulation
Trigger point injections
Botulinum toxin injections
New bladder instillations
Medications that can be administered through the vagina or rectum
Neuromodulation
Interferential transcutaneous nerve stimulation (iTENS)
Diet changes
* Two new studies for Interstitial Cystitis patients were discussed
-Caffeine study. Interstitial cystitis patients who feel that they are “coffee sensitive” are encouraged to participate. The project is designed to determine whether caffeine is actually the cause of IC related symptoms. If interested in participating, please contact Dr. Sadek (516) 734-8565.
-Nerve growth factor Immunoglobulin study (Tanezumab) for Interstitial Cystitis. This is a study which will likely start in May 2010. For more information, please contact Monica Johnson, RN, our new clinical research coordinator, (516) 734-8515.
